VAERS reports by lot

GSK Varicella/Shingles lot T44C7: VAERS reports

38 VAERS reports list lot T44C7 as a GSK Varicella/Shingles vaccine, received between 2019-12-27 and 2021-09-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
3%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2321%
Dermatological (non-injection-site)1816%
General / Systemic (non-local)1614%
Allergic / Anaphylactic1412%
Musculoskeletal1312%
Neurological1110%
Cardiac / Cardiovascular87%
Gastrointestinal54%
Autoimmune / Immune-mediated22%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania12
Georgia7
Ohio5
Florida4
Kentucky2
Michigan1
Oklahoma1
Connecticut1
New York1
Texas1
Indiana1
Wisconsin1

Reports by month received

2019-125
2020-018
2020-0210
2020-032
2020-052
2020-062
2020-073
2020-102
2020-111
2020-121
2021-021
2021-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.